๐Ÿ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cellectricon

1.1 - Company Overview

Cellectricon Logo

Cellectricon

Headquarter: Sweden
Founded: 20XX๐Ÿ”’
Employees: 100-500๐Ÿ”’
๐ŸŒ Website

Company description

  • Provider of advanced cell-based screening services to accelerate drug discovery, exploiting the Cellaxessยฎ Elektra platform. Discovery Services are ideal for compound profiling in excitable primary cells and native tissue, helping researchers identify phenotypic effects.

Products and services

๐Ÿ”’

Key contacts

๐Ÿ”’
๐Ÿ”’

Financial details

๐Ÿ”’

1.2 - Competitors and similar companies to Cellectricon

Lino Biotech Logo

Lino Biotech

HQ: Switzerland Website
  • Description: Provider of focal molographyโ€”an entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samplesโ€”eliminating signal disturbances due to temperature changes or non-specific binding.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Lino Biotech company profile โ†’
Numerate Logo

Numerate

HQ: United States Website
  • Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Numerate company profile โ†’
Harbour Antibodies Logo

Harbour Antibodies

HQ: United States Website
  • Description: Provider of transgenic mouse technology for engineering mice to produce high affinity human antibodies. Established in 2006, leveraging technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands). The company has developed two types of human immunoglobulin gene transgenic mice.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Harbour Antibodies company profile โ†’
Prism Pharma Logo

Prism Pharma

HQ: United States Website
  • Description: Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Prism Pharma company profile โ†’
Sarissa Biomedical Logo

Sarissa Biomedical

HQ: United Kingdom Website
  • Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Sarissa Biomedical company profile โ†’
๐Ÿ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

๐Ÿ”’
๐Ÿ”’
๐Ÿ”’
๐Ÿ”’ View all strategic buyers with complete profiles
Start Free Trial โ†’

2.2 - Strategic buyer groups for Cellectricon

๐Ÿ”’

Buyer group 1: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 2: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 3: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cellectricon

2.2 - Growth funds investing in similar companies to Cellectricon

๐Ÿ”’ View all growth equity funds with complete profiles
Start Free Trial โ†’

4 - Top valuation comps for Cellectricon

4.2 - Public trading comparable groups for Cellectricon

๐Ÿ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ†’

4.3 - M&A Transactions similar to Cellectricon

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
๐Ÿ”’ View all M&A transactions with complete deal terms
Request Free Trial Now โ†’

Frequently Asked Questions

About Cellectricon

What does Cellectricon do?

Cellectricon is a provider of advanced cell-based screening services to accelerate drug discovery, exploiting the Cellaxessยฎ Elektra platform. Discovery Services are ideal for compound profiling in excitable primary cells and native tissue, helping researchers identify phenotypic effects.

Who are Cellectricon's competitors?

Cellectricon's competitors and similar companies include Lino Biotech, Numerate, Harbour Antibodies, Prism Pharma, and Sarissa Biomedical.

Where is Cellectricon headquartered?

Cellectricon is headquartered in Sweden.

How many employees does Cellectricon have?

Cellectricon has 1,000 employees ๐Ÿ”’.

When was Cellectricon founded?

Cellectricon was founded in 2010 ๐Ÿ”’.

What sector and industry vertical is Cellectricon in?

Cellectricon is in the Enterprise Software ๐Ÿ”’ sector and industry

M&A Buyers & Acquirers for Cellectricon

Who are the top strategic acquirers in Cellectricon's sector and industry

Top strategic M&A buyers and acquirers in Cellectricon's sector include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which M&A buyer groups are most relevant for Cellectricon?

Top strategic M&A buyers groups and sectors for Cellectricon include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ , โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Financial Investors investing in Cellectricon's sector and industry vertical

Which are the top PE firms investing in Cellectricon's sector and industry vertical?

Top PE firms investing in Cellectricon's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top buyout funds acquiring in Cellectricon's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cellectricon's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top growth equity funds investing in companies in Cellectricon's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cellectricon include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Valuation benchmarks of companies in Cellectricon's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cellectricon?

The key public trading comparables and valuation benchmarks for Cellectricon include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which are the key trading comparable groups for Cellectricon for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cellectricon with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cellectricon's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cellectricon with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cellectricon's' sector and industry vertical?

Access recent funding rounds and capital raises in Cellectricon's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cellectricon

Launch login modal Launch register modal